Related Experiment Videos
Cardiac autotransplantation for mitral valve replacement
Dimitri Novitzky1, Richard Perry, David Ndaba
1Tampa Veterans Administration Medical Center and University of South Florida, Tampa, Florida 33612, USA. novitzky@aol.com
The Heart Surgery Forum
|January 15, 2004
Summary
Severe mitral regurgitation and coronary artery disease required complex surgery. Ex vivo mitral valve replacement and reimplantation proved successful when standard approaches failed, offering a viable option for challenging cases.
Area of Science:
- Cardiovascular Surgery
- Cardiac Transplantation
- Surgical Innovation
Background:
- Severe mitral valve regurgitation and extensive coronary artery disease present complex surgical challenges.
- Standard surgical approaches may lead to inadequate visualization and access to the mitral valve annulus.
Observation:
- A case report details a 69-year-old patient requiring mitral valve replacement and myocardial revascularization.
- Transatrial transseptal approach provided insufficient visualization, necessitating heart explantation for ex vivo mitral valve replacement.
- The heart was reimplanted after successful ex vivo valve replacement, with the patient remaining well for 7 years.
Findings:
- A survey of 1120 cardiothoracic surgeons revealed 70% experienced inadequate mitral valve exposure.
- 50% extended atrial incisions, and others divided vena cavae to improve exposure.
- 4% of surgeons abandoned operations due to poor exposure, leading to 320 perioperative deaths.
Implications:
- Ex vivo mitral valve replacement and reimplantation is a viable strategy for cases with impossible mitral valve access using standard techniques.
- This approach can potentially prevent surgical abandonment and associated mortality in complex cardiac surgeries.
- Further research into optimizing ex vivo cardiac procedures is warranted.